About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Zydus Lifesciences Ltd.
BSE Code
532321
ISIN Demat
INE010B01027
Book Value
215.08
NSE Code
ZYDUSLIFE
Dividend Yield %
1.19
Market Cap
934036.70
P/E
19.36
EPS
47.96
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
18-Nov-2025
940.05
940.05
926.80
928.25
9386
8734195
17-Nov-2025
949.00
949.00
932.85
934.30
32504
30462320
14-Nov-2025
950.65
952.60
939.65
943.95
25664
24279502
13-Nov-2025
959.45
959.45
940.20
944.20
8582
8120121
12-Nov-2025
938.05
957.50
938.05
951.20
13573
12904145
11-Nov-2025
948.35
948.35
935.60
938.05
11995
11268002
10-Nov-2025
952.40
954.30
942.20
947.05
15238
14469989
07-Nov-2025
939.45
945.80
927.00
943.80
17982
16840132
06-Nov-2025
985.95
985.95
933.05
936.25
166107
159947026
04-Nov-2025
981.70
987.35
968.80
972.85
19334
18910696
03-Nov-2025
969.95
983.00
969.95
980.75
19989
19519555
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.